Lu YuFen, Chen Yu, Zhang ZiYu, Li MingMei, Chen XiaoXiao, Tu KaiJia, Li LongYu
Medical College of Nanchang University, Nanchang, Jiangxi, People's Republic of China.
The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, People's Republic of China.
Cell Biol Int. 2022 Apr;46(4):599-610. doi: 10.1002/cbin.11756. Epub 2022 Jan 15.
In most cases of cervical cancer, the high risk of the disease is caused by the human papilloma virus (HPV). Surgery or radiation usually benefits patients with early cervical cancer, while the metastatic one is uncurable and new therapeutic strategies and approaches are required. In this study, HPV16 E6 silence or overexpression were carried out to evaluate the possible mechanisms of HPV16 E6 function in cervical cancer cells with different HPV16 E6 expression background. HPV16 E6-positive cervical cancer cell Siha exerts significantly stronger cell invasion and migration potentials than the HPV16 E6-negative C33A cells. HPV16 E6 silence significantly weakened the potentials of cell invasion and migration, cell proliferation and stemness characteristic in Siha cells. Meanwhile, the overexpression of HPV16 E6 effectively promoted the cell proliferation and stemness characteristic in C33A cells. Our data also indicated a positive association between HPV16 E6 and the levels of epithelial to mesenchymal transition (EMT), and cell stemness. The ectopic expression of OCT4 could effectively reverse the inhibitory roles of HPV16 E6 silence on cell migration, invasion, and stemness in Siha cells. More interestingly, we found that HPV16 E6 might promote the OCT4 expression by impairing the direct binding of p53 on the promoter and activate its transcription. Taken together, our results indicated that HPV16 E6 could promoted the potential cell proliferation, migration, and invasion of human cervical cancer cells by modulating EMT and cell stemness. Our data provide a novel mechanism for how HPV16 E6 acts as a key risk factor for cervical cancer development and progression.
在大多数宫颈癌病例中,该疾病的高风险是由人乳头瘤病毒(HPV)引起的。手术或放疗通常对早期宫颈癌患者有益,而转移性宫颈癌则无法治愈,需要新的治疗策略和方法。在本研究中,进行了HPV16 E6沉默或过表达实验,以评估在不同HPV16 E6表达背景的宫颈癌细胞中HPV16 E6功能的可能机制。HPV16 E6阳性的宫颈癌细胞Siha比HPV16 E6阴性的C33A细胞具有明显更强的细胞侵袭和迁移能力。HPV16 E6沉默显著削弱了Siha细胞的侵袭和迁移能力、细胞增殖能力以及干性特征。同时,HPV16 E6的过表达有效促进了C33A细胞的增殖和干性特征。我们的数据还表明HPV16 E6与上皮-间质转化(EMT)水平和细胞干性之间呈正相关。OCT4的异位表达可有效逆转HPV16 E6沉默对Siha细胞迁移、侵袭和干性的抑制作用。更有趣的是,我们发现HPV16 E6可能通过削弱p53与启动子的直接结合来促进OCT4表达并激活其转录。综上所述,我们的结果表明HPV16 E6可通过调节EMT和细胞干性来促进人宫颈癌细胞的潜在增殖、迁移和侵袭。我们的数据为HPV16 E6如何作为宫颈癌发生和发展的关键风险因素提供了一种新机制。